Option chain shows key data for Grifols's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Grifols.

Grifols (OTC:GIKLY) Stock, Option Chain

GRIFOLS SA ADR

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

Short Ideas

Trading Ideas

GIKLY

On Wednesday, shares of Grifols Sa (OTC: GIKLY) experienced volatile short activity. After the activity, the stock price went up +0% to $5.93.

The overall sentiment for GIKLY has been Bearish.

Short Volatility Alert: Grifols Sa

Grifols SA

Grifols: Q4 Was Positive, Still Too Many Question Marks

Harris Associates International Small Cap Strategy Q1 2024 Commentary

Showcasing Seeking Alpha's May 2024 New Analysts

Grifols receives takeover interest from its founding family, Brookfield fund; to go private

Grifols: Stay On The Sidelines

Grifols: Going Private? Brookfield On The Scene

Undercovered Dozen: Spirit Airlines, HubSpot, Cigna, First Quantum Minerals +

Grifols Class B stock falls as Brookfield reportedly seeks lower price

GigaGen awarded $135.2M U.S. Dept of Health contract for its polyclonal antibody therapy

Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down

APLUF

ARVN

BKNG

DITHF

DSSMY

DXCM

FLMNF

FLMNY

FLNG

FNKO

FQVLF

GIFLF

GIFOF

GOLD

GOOG

GOOGL

GRFS

HOOD

HUBS

INTC

INTR

JAKK

KNCRF

KNCRY

KREF

KRNGF

KRNGY

LAAOF

MHSDF

NESRF

NEXPF

NEXXY

NSTYY

PARA

PARAA

PSNY

PSNYW

RBRK

SAVE

STJPF

TISNF

TRUBF

USFR

VGLT

VRNOF

VTSCF

VTSCY

Press Releases

ROSEN, A LEADING NATIONAL FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

Small Cap

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

ROSEN, A LEADING LAW FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

News

Legal

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

Grifols

Comments

Grifols

Grifols (GIKLY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga